Abstract: A method for treating mastitis in a domestic animal in need of such a treatment, which comprises administering to the animal a pharmaceutical composition comprising a rifamycin derivative of the formula (1): wherein R is an alkyl group having 1 to 7 carbon atoms or a physiologically acceptable salt thereof as an active ingredient, and a physiologically acceptable carrier. The present invention provides a novel therapeutic method effective for treatment of mastitis caused by bacterial infection in a domestic animal.

Abstract: Antibacterial compositions comprising (1) a rifamycin derivative represented by the formula (I) or its physiologically acceptable salt, and (2) a proton pump inhibitor (a) or a bismuth preparation (b) wherein the components (1) and (2) are used in such amounts as producing a synergistic effect against Helicobacter pylori, drugs and remedies for digestive organ diseases which contain the antibacterial compositions, process for producing them, and pharmaceutical preparations related to the antibacterial compositions. The compositions can be administered to patients with digestive diseases caused by infection of Helicobacter pylori in a smaller dose and at a lower administration frequency as compared with conventional remedies.

Abstract: A method for treating a digestive organ disease caused by the infection of Helicobacter, comprising administering a rifamycin derivative expressed by the formula (I), or a physiologically acceptable salt thereof ##STR1##

Abstract: A method for treatment of diseases caused by Chlamydia infection is disclosed comprising administering a rifamycin of the formula (I): ##STR1## wherein R.sup.1 is hydrogen atom or acetyl, and X is oxygen, sulfur or a group NR, in which R is hydrogen, an alkyl group having 1 to 7 carbon atoms or a group of the formula (II): ##STR2## in which n is an integer of 1 to 3; or a physiologically acceptable salt thereof.

Abstract: Electroluminescent element includes two dielectric layers disposed on either side of a luminescent layer wherein a transparent electrode and a backing electrode are formed on respective dielectric layers. In a preferred embodiment, the dielectric films include tantalum oxide and at least one oxide of either indium, tin, or zinc wherein the total content of the indium, tin, and zinc atoms in the dielectric layer comprise 55 atomic % or less with respect to the total content of tantalum, indium, tin, and zinc atoms. The dielectric films have a relatively high dielectric constant and high breakdown strength.

Abstract: A rifamycin derivative having the formula (I): ##STR1## wherein A is a group having the formula: ##STR2## in which R.sup.1 is an alkyl group having 4 or 5 carbon atoms or an alkenyl group having 3 to 5 carbon atoms, or a group having the formula: in which n is 3 or 4; or a pharmaceutically acceptable salt thereof. The rifamycin derivative (I) exhibits a strong antibacterial activity against Gram-positive bacteria and acid-fast bacteria, and also exhibits a strong antibacterial activity against tubercle bacilli.

Abstract: A rifamycin derivative having the formula (I): ##STR1## wherein R.sup.1 is hydrogen atom, methyl group or ethyl group, R.sup.2 is an alkyl group having 1 to 4 carbon atoms, and A is a group having the formula: ##STR2## in which n is an integer of 3 to 5, or group having the formula: ##STR3## in which R.sup.3 is a alkyl group having 1 to 5 carbon atoms; or a salt thereof. The rifamycin derivative (I) exhibits a strong antibacterial activity against Gram-positive bacteria and acid-fast bacteria, and also exhibits a strong antibacterial activity against tubercle bacilli.

Abstract: A novel rifamycin derivative having the formula (I): ##STR1## wherein X.sup.1 is an alkyl group with 1 to 6 carbon atoms or a cycloalkyl group with 3 to 8 carbon atoms; X.sup.2 is a hydrogen atom or an alkyl group with 1 to 4 carbon atoms; R.sup.1 is hydrogen atom or acetyl group; A is a group represented by the formula: ##STR2## wherein R.sup.2 is an alkyl group with 1 to 4 carbon atoms or an alkoxyalkyl group with 2 to 6 carbon atoms and R.sup.3 is an alkyl group with 1 to 6 carbon atoms or an alkoxyalkyl group with 2 to 6 carbon atoms, or a group represented by the formula ##STR3## wherein ##STR4## is a 3 to 9 membered cyclic amino group with 2 to 8 carbon atoms, R.sup.4 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, or salts thereof, a process for preparing the same and antibacterial agents containing the same as an effective ingredient.

Abstract: A novel rifamycin derivative having the general formula (I): ##STR1## or salts thereof, a process for preparing the same and antibacterial agents containing the same as an effective component.The rifamycin derivative of the present invention having the general formula (I) shows a strong antibacterial activity against the Gram-positive bacteria and the acid-fast bacteria.

Abstract: A chemical analyzer is disclosed in which a sample is supplied from a sample cup on a sample table to an array of reaction cups on a reaction table so that the reaction cups contain the same amount of sample, a reagent pipetting nozzle sucks an appropriate reagent solution from an array of reagent tanks and discharges the reagent solution into a corresponding reaction cup, the sample having reacted with the reagent solution is optically measured by a multi-wavelength photometer, a plurality of reagent tanks containing different reagent solutions are placed in a refrigerator with the openings of the reagent tanks being directed upward, the refrigerator is provided with a cover which has holes provided at positions corresponding to the openings of the reagent tanks, these holes are closed by a shutter except when the reagent pipetting nozzle is inserted into these holes, the array of reaction cups is immersed in constant-temperature-water contained in a reaction bath, the reaction bath is supplied with water wh

Abstract: An automatic chemical analyzer suitable for chemically analyzing a number of analysis items is disclosed. Samples in sample containers are sequentially dispensed to an array of reaction vessels using a first pipetting tube. Reagent solutions selected in accordance with the analysis items are fed to the reaction vessels using a second conductive pipetting tube. The reaction solutions in the reaction vessels are measured by a photometer. When the reagent solutions are sucked into the second pipetting tube, the liquid levels of the reagent solutions in the reagent containers are detected by a liquid level sensor formed by the second pipetting tube and a conductive electrode. The amounts of the reagent solutions remaining in the reagent containers are determined based on the position of the liquid level sensor and the numbers of times of dispense allowed to the reagent solutions with respect to the analysis items are displayed on a cathode ray tube.

Abstract: A new anti-inflammatory, analgesic, and antipyretic pharmaceutical composition is disclosed which contains a 3,5-di-tert-butyl-4-hydroxystyrene derivative of the formula: ##STR1## wherein R.sup.1 stands for a group represented by COR.sup.3 [R.sup.3 denotes a group of OR.sup.4 (R.sup.4 is a hydrogen atom or an alkyl group with C.sub.1 .about.C.sub.4), an alkyl group with C.sub.1 .about.C.sub.3, a phenyl group, or an amino group], a nitro group, or an alkylsulfonyl group represented by SO.sub.2 R.sup.5 (R.sup.5 is an alkyl group with C.sub.1 .about.C.sub.3); and R.sup.2 stands for a hydrogen atom, an alkyl group with C.sub.1 .about.C.sub.4, a hydroxyalkyl group with C.sub.1 .about.C.sub.4, a cyano group, or an acyl group represented by COR.sup.6 (R.sup.6 is an alkyl group with C.sub.1 .about.C.sub.3),or its pharmaceutically acceptable salt as an active ingredient in association with pharmaceutical excipients.

Abstract: Novel compounds, 3,5-di-tert-butylstyrene derivatives and their salts, are disclosed, which derivatives are represented by the general formula: ##STR1## wherein R.sup.1 stands for an acyloxy group represented by R.sup.3 COO (R.sup.3 is a hydrogen atom or an alkyl group with C.sub.1 -C.sub.6), an alkoxyl group of R.sub.4 O (R.sup.4 is an alkyl group with C.sub.1 -C.sub.4), a hydroxyl group, or a hydrogen atom; R.sup.2 stands for ##STR2## (R.sup.5 is a hydrogen atom or an alkyl group with C.sub.1 -C.sub.3 and X.sup.1 is CH.sub.2 or an oxygen atom), ##STR3## (R.sup.5 and X.sup.1 are each the same as defined above), or ##STR4## (X.sup.2 is an oxygen or sulfur atom).

Abstract: A train of cuvettes are held on a turntable and serum specimen is sequentially sampled each time the turntable makes a revolution through more than 360.degree.. While the turntable is at rest, blank solution is poured into one cuvette, reagent is put into another cuvette and reactant solution is drawn out of still another cuvette in specified positions respectively in the path along which the train of cuvettes are conveyed. During a single rotational operation of the turntable, these cuvettes sequentially transverses the light path in the photometer so that the light absorbances for the respective cuvettes are measured. Both the absorbances for cuvettes containing reactant solutions for different samples and the absorbance for a cuvette containing only the blank solution are measured by a single photometer.

Abstract: In an automatic chemical analyzing method and apparatus in which a plurality of samples each added with a reagent are discretely transported through a reaction line and subjected to a reaction during the transportation for optical measurement to generate measured signals and to process them, the samples to be analyzed are grouped into a plurality of sample groups each including a plurality of samples which are to be measured with respect to the same test items, which are previously stored for each sample group in a memory of a central control unit. The samples are divided by a number corresponding to the number of test items and successively fed to the reaction line one by one in sample groups, and, at the time of change of the sample group receiving the analysis, test items corresponding to a new sample group are read from the memory to carry out a chemical analysis for the samples in each sample group according to the read test items.